Drug price to cut when its unfair trade identified in the market.

The KPMA worried that some drug companies were exercising unfair trade activities with medical institutes, by providing a special rebate to them in return of more prescribing their own products, and therefore made it clear by announcing on Sept. 19 that strict administrative measures including price reduction for particular drugs would be requested to the government if such unfair deals were id...